Frey Patrick, Cheng Phil, Schmid-Grendelmeier Peter, Guillet Carole
Allergy Unit, Department of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.
Department of Internal Medicine, Cantonal Hospital Baden, Im Ergel 1, 5404 Baden, Switzerland.
Int J Mol Sci. 2025 Jun 11;26(12):5616. doi: 10.3390/ijms26125616.
Grass pollen allergies significantly contribute to atopic diseases such as asthma and allergic rhinitis, resulting in considerable healthcare burdens. Objective: In this study, molecular sensitization patterns to grass pollen in Swiss patients were addressed. The research utilized a retrospective cohort approach using ImmunoCAP™ ISAC testing from October 2015 to July 2020. Clinical histories, demographics, and skin prick test results were collected for analysis. The minimum patient age was 18 years and the average patient age was 41.3 years, with a female predominance (68.5%). In total, 4814 measurements were analyzed. Allergic rhinitis was the most common clinical symptom, followed by asthma and urticaria. A total of 1963 patients (40.8%) revealed sensitization to grass pollen. The most common sensitizations were found to the major allergens Phl p 1 (86%) and Phl p 5 (65%), but also to Phl p 4 (62%). Monosensitization was mostly found to allergens Phl p 1 (266/13.5%) and Phl p 4 (157/7.9%), and less so to Phl p 5 (33/1.7%). Notably, the Phl p 4-monosensitized subgroup showed only an 18% positivity rate in skin prick tests and presented mostly with urticaria. This study gives insights into the spectrum of grass pollen allergies in a Central European setting and underscores the possibly underestimated role of Phl p 4 among grass pollen allergens, especially in a subgroup that suffers mainly from seasonal urticaria. Monovalent sensitization to Phl p 4 can also cause seasonal rhinitis and might therefore be missed if only Phl p 1/p 5 are tested. A better understanding of sensitization patterns will further improve diagnosis and treatment options.
草花粉过敏是导致哮喘和过敏性鼻炎等特应性疾病的重要因素,给医疗保健带来了沉重负担。目的:本研究探讨了瑞士患者对草花粉的分子致敏模式。该研究采用回顾性队列研究方法,使用ImmunoCAP™ ISAC检测,时间跨度为2015年10月至2020年7月。收集临床病史、人口统计学资料和皮肤点刺试验结果进行分析。患者最小年龄为18岁,平均年龄为41.3岁,女性占多数(68.5%)。总共分析了4814次检测结果。过敏性鼻炎是最常见的临床症状,其次是哮喘和荨麻疹。共有1963名患者(40.8%)对草花粉致敏。最常见的致敏原是主要过敏原Phl p 1(86%)和Phl p 5(65%),还有Phl p 4(62%)。单致敏主要见于过敏原Phl p 1(266/13.5%)和Phl p 4(157/7.9%),而Phl p 5较少(33/1.7%)。值得注意的是,Phl p 4单致敏亚组在皮肤点刺试验中的阳性率仅为18%,主要表现为荨麻疹。本研究深入了解了中欧地区草花粉过敏的情况,并强调了Phl p 4在草花粉过敏原中可能被低估的作用,特别是在主要患有季节性荨麻疹的亚组中。对Phl p 4的单价致敏也可引起季节性鼻炎,因此如果仅检测Phl p 1/p 5可能会漏诊。更好地了解致敏模式将进一步改善诊断和治疗方案。